ロード中...
Hemophilia therapy: the future has begun
The success story of hemophilia care first began in the 1970s, when the availability of plasma-derived concentrates of coagulation factor VIII (FVIII) and factor IX (FIX) provided efficacious treatment of bleeding in patients with hemophilia A and B. This positive scenario was consolidated in terms...
保存先:
| 出版年: | Haematologica |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Ferrata Storti Foundation
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7049365/ https://ncbi.nlm.nih.gov/pubmed/32060150 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2019.232132 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|